Giménez E - Search Results

1

Cytomegalovirus DNAemia and risk of mortality in allogeneic hematopoietic stem cell transplantation: Analysis from the Spanish Hematopoietic Transplantation and Cell Therapy Group.

Solano C, Vázquez L, Giménez E, de la Cámara R, Albert E, Rovira M, Espigado I, Calvo CM, López-Jiménez J, Suárez-Lledó M, Chinea A, Esquirol A, Pérez A, Bermúdez A, Saldaña R, Heras I, González-Huerta AJ, Torrado T, Bautista G, Batlle M, Jiménez S, Vallejo C, Barba P, Cuesta MÁ, Piñana JL, Navarro D. Solano C, et al. Among authors: gimenez e. Am J Transplant. 2021 Jan;21(1):258-271. doi: 10.1111/ajt.16147. Epub 2020 Jul 15. Am J Transplant. 2021. PMID: 32812351 Free article.

2

Comparison of the new Abbott Real Time CMV assay and the Abbott CMV PCR Kit for the quantitation of plasma cytomegalovirus DNAemia.

Clari MÁ, Bravo D, Costa E, Muñoz-Cobo B, Solano C, Remigia MJ, Giménez E, Benmarzouk-Hidalgo OJ, Pérez-Romero P, Navarro D. Clari MÁ, et al. Among authors: gimenez e. Diagn Microbiol Infect Dis. 2013 Feb;75(2):207-9. doi: 10.1016/j.diagmicrobio.2012.10.010. Epub 2012 Nov 20. Diagn Microbiol Infect Dis. 2013. PMID: 23182073

3

Pre-emptive antiviral therapy for active CMV infection in adult allo-SCT patients guided by plasma CMV DNAemia quantitation using a real-time PCR assay: clinical experience at a single center.

Solano C, Muñoz-Cobo B, Giménez E, Remigia MJ, Amat P, Clari MA, Bravo D, Benet I, Montoro J, Navarro D. Solano C, et al. Among authors: gimenez e. Bone Marrow Transplant. 2013 Jul;48(7):1010-2. doi: 10.1038/bmt.2012.286. Epub 2013 Jan 21. Bone Marrow Transplant. 2013. PMID: 23334275 No abstract available.

4

Evaluation of cytomegalovirus (CMV)-specific T-cell immunity for the assessment of the risk of active CMV infection in non-immunosuppressed surgical and trauma intensive care unit patients.

Clari MA, Aguilar G, Benet I, Belda J, Giménez E, Bravo D, Carbonell JA, Henao L, Navarro D. Clari MA, et al. Among authors: gimenez e. J Med Virol. 2013 Oct;85(10):1802-10. doi: 10.1002/jmv.23621. Epub 2013 Jul 19. J Med Virol. 2013. PMID: 23868746

5

An investigation on the relationship between the occurrence of CMV DNAemia and the development of invasive aspergillosis in the allogeneic stem cell transplantation setting.

Giménez E, Solano C, Nieto J, Remigia MJ, Clari MÁ, Costa E, Muñoz-Cobo B, Amat P, Bravo D, Benet I, Navarro D. Giménez E, et al. J Med Virol. 2014 Apr;86(4):568-75. doi: 10.1002/jmv.23735. Epub 2013 Sep 13. J Med Virol. 2014. PMID: 24037906

6

An evaluation of the role of NKG2C+ natural killer cells in protection from cytomegalovirus DNAemia early following allogeneic stem cell transplantation.

Muñoz-Cobo B, Giménez E, Solano C, de la Cámara R, Nieto J, López J, Amat P, Garcia-Noblejas A, Navarro D. Muñoz-Cobo B, et al. Among authors: gimenez e. J Med Virol. 2014 May;86(5):806-11. doi: 10.1002/jmv.23742. Epub 2013 Sep 16. J Med Virol. 2014. PMID: 24105728

7

Effect of the IL28B Rs12979860 C/T polymorphism on the incidence and features of active cytomegalovirus infection in allogeneic stem cell transplant patients.

Bravo D, Solano C, Giménez E, Remigia MJ, Corrales I, Amat P, Navarro D. Bravo D, et al. Among authors: gimenez e. J Med Virol. 2014 May;86(5):838-44. doi: 10.1002/jmv.23865. Epub 2013 Dec 27. J Med Virol. 2014. PMID: 24374819

8

Looking for biological factors to predict the risk of active cytomegalovirus infection in non-immunosuppressed critically ill patients.

Bravo D, Clari MA, Aguilar G, Belda J, Giménez E, Carbonell JA, Henao L, Navarro D. Bravo D, et al. Among authors: gimenez e. J Med Virol. 2014 May;86(5):827-33. doi: 10.1002/jmv.23838. Epub 2013 Nov 5. J Med Virol. 2014. PMID: 24431153

9

Early kinetics of plasma cytomegalovirus DNA load in allogeneic stem cell transplant recipients in the era of highly sensitive real-time PCR assays: does it have any clinical value?

Giménez E, Muñoz-Cobo B, Solano C, Amat P, Navarro D. Giménez E, et al. J Clin Microbiol. 2014 Feb;52(2):654-6. doi: 10.1128/JCM.02571-13. Epub 2013 Nov 27. J Clin Microbiol. 2014. PMID: 24478505 Free PMC article.

10

Evaluation of the Architect Epstein-Barr Virus (EBV) viral capsid antigen (VCA) IgG, VCA IgM, and EBV nuclear antigen 1 IgG chemiluminescent immunoassays for detection of EBV antibodies and categorization of EBV infection status using immunofluorescence assays as the reference method.

Corrales I, Giménez E, Navarro D. Corrales I, et al. Among authors: gimenez e. Clin Vaccine Immunol. 2014 May;21(5):684-8. doi: 10.1128/CVI.00104-14. Epub 2014 Mar 12. Clin Vaccine Immunol. 2014. PMID: 24623623 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

361 results

Search Page

Filters